
AgonOx, INC.
Portland, OR, United States · agonox.com
AgonOx, INC. develops T cell-based immunotherapy approaches for cancer. It works on tumor-infiltrating lymphocytes (TIL) and immune targets for solid tumors, with activity in Portland, Oregon.
They take quote requests by email.
What they offer
T cell therapy development
Develops T cell-based therapies for cancer, including its lead program AGX-148.
Tumor-infiltrating lymphocyte (TIL) isolation and expansion
Isolates and expands the CD39+CD103+ subset of a patient's tumor-infiltrating lymphocytes.
Immunotherapy target discovery
Identifies new immunotherapy targets by studying human tumor-infiltrating lymphocytes from different tumor types.
Recombinant protein design and development
Designs recombinant proteins that block and/or activate novel immune-specific pathways.
Small-molecule discovery and development
Develops small molecules to block and/or activate immune-specific pathways.
In vitro human immune assays
Tests candidate agents in immune-specific in vitro human assays.
Mouse tumor model testing
Evaluates candidate agents in mouse tumor models.
What they work on
- Modalities
- Small molecule, Antibody, Cell therapy, Recombinant protein
- Species and models
- human tumor specimens, mouse tumor models
- Assays and studies
- immune-specific in vitro human assays, RNA array data analysis
- Therapeutic areas
- cancer, solid tumors
- Sites
- Portland, USA
Similar labs. Biocytogen, CDI Labs, Oncodesign Services, Abnova
Found in a contract services directory. Listing built from agonox.com. Work here? Claim this listing.